Careers  |  Sign In  |  Register

Latest in Oncology

In this interview, Omid Hamid, MD, discusses the current landscape of targeted therapies in melanoma. He shares his thoughts about immune response, triplet therapy, and soon-to-be-released data that suggests progression-free survival (PFS) is increased with the use of these targeted therapies. Learn more...
Mark M. Awad, MD, PhD, assistant professor of Medicine at Harvard Medical School and clinical director of the Thoracic Oncology Treatment Center at Dana-Farber Cancer Institute, shares insights into a recent study, conducted in collaboration with Foundation Medicine, that looked at 60,000 patients with...
[case_player][/case_player] Paula J. Bates, PhD, professor of medicine at the University of Louisville School of Medicine, and colleagues John O. Trent, PhD, and Donald M. Miller, MD, PhD, have been developing a cancer therapy based on their discovery of a synthetic piece of DNA known as an aptamer. This...